研究

Hashimoto M, Shimizu N, Nishimoto M, Minami T, Fujita K, Yoshimura K, Hirayama A, Uemura H.

Sarcopenia and Visceral Obesity are Significantly Related to Severe Storage Symptoms in Geriatric Female Patients

Hashimoto M, Fujita K, Nakayama T, Fujimoto S, Hamaguchi M, Nishimoto M, Kikuchi T, Adomi S, Banno E, De Velasco MA, Saito Y, Shimizu N, Mori Y, Minami T, Nozawa M, Nose K, Yoshimura K, Uemura H.

Higher neutrophil-to-lymphocyte ratio after the first cycle of the first-line chemotherapy is associated with poor cancer specific survival of upper urinary tract carcinoma patients.

Fujita K.

Urinary biomarkers of urological malignancies

Uemura H, Arai G, Uemura H, Suzuki H, Iijima K, Nishimura K, Fujii K, Hatayama T, Aoyama J, Deprince K, Lopez-Gitlitz A, McCarthy S, Larsen JS, Li J, Chi KN.

Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study.

Fujita K, Hatano K, Tomiyama E, Hayashi Y, Matsushita M, Tsuchiya M, Yoshikawa T, Date M, Miyoshi E, Nonomura N.

Serum core-type fucosylated prostate-specific antigen index for the detection of high-risk prostate cancer.

Uemura H, Masumori N, Takahashi S, Hosono M, Kinuya S, Sunaya T, Horio T, Okayama Y, Kakehi Y.

Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents

Matsumura N, Fujita K, Nishimoto M, Yamamoto Y, Kuwahara K, Nagai Y, Minami T, Hatanaka Y, Nozawa M, Morimoto Y, Tahara H, Uejima S, Esa A, Hirayama A, Yoshimura K and Uemura H

Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Propensity Score-Matched Analysis.

Fujita K, Hatano K, Hashimoto M, Tomiyama E, Miyoshi E, Nonomura N, Uemura H.

Fucosylation in Urological Cancers.

Takezawa K, Fujita K, Matsushita M, Motooka D, Hatano K, Banno E, Shimizu N, Takao T, Takada S, Okada K, Fukuhara S, Kiuchi H, Uemura H, Nakamura S, Kojima Y, Nonomura N.

The Firmicutes/Bacteroidetes ratio of the human gut microbiota is associated with prostate enlargement.

Matsushita M, Fujita K, Motooka D, Hatano K, Fukae S, Kawamura N, Tomiyama E, Hayashi Y, Banno E, Takao T, Takada S, Yachida S, Uemura H, Nakamura S, Nonomura N.

The gut microbiota associated with high-Gleason prostate cancer.

Matsushita M, Fujita K, Hayashi T, Kayama H, Motooka D, Hase H, Jingushi K, Yamamichi G, Yumiba S, Tomiyama E, Koh Y, Hayashi Y, Nakano K, Wang C, Ishizuya Y, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Imamura R, Rodriguez Pena MDC, Gordetsky JB, Netto GJ, Tsujikawa K, Nakamura S, Takeda K, Nonomura N.

Gut Microbiota-Derived Short-Chain Fatty Acids Promote Prostate Cancer Growth via IGF1 Signaling.

Hayashi Y, Fujita K, Netto GJ, Nonomura N.

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma.

Nojima S, Terayama K, Shimoura S, Hijiki S, Nonomura N, Morii E, Okuno Y, Fujita K.

A deep learning system to diagnose the malignant potential of urothelial carcinoma cells in cytology specimens.

Hayashi Y, Fujita K, Banno E, Eich ML, Netto GJ, Nonomura N.

Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.

Matsuzaki K, Fujita K*, Tomiyama E, Hatano K, Hayashi Y, Wang C, Ishizuya Y, Yamamoto Y, Hayashi T, Kato T, Jingushi K, Kawashima A, Ujike T, Nagahara A, Uemura M, Tsujikawa K, Nonomura N.

MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer.

Hatano K, Fujita K.

Extracellular vesicles in prostate cancer: a narrative review.

Hayashi Y, Fujita K.

Toward urinary cell-free DNA-based treatment of urothelial carcinoma: a narrative review.

Tomiyama E, Matsuzaki K, Fujita K, Shiromizu T, Narumi R, Jingushi K, Koh Y, Matsushita M, Nakano K, Hayashi Y, Wang C, Ishizuya Y, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Takao T, Adachi J, Tomonaga T, Nonomura N.

Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers.

Tomiyama E, Fujita K, Nonomura N.

Urinary Extracellular Vesicles: Ultracentrifugation Method.

Okada K, Fujita K, Fukuhara S, Kiuchi H, Uemura M, Imamura R, Nonomura N.

Erectile Dysfunction in Germ Cell Tumor Survivors.